Connect with us

Technology

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

Published

on

LAUSANNE, Switzerland, Jan. 2, 2025 /PRNewswire/ — ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that the Company has made grants of options to purchase an aggregate of 20,000 of the Company’s common shares to two new employees on January 2, 2025 (each, a “Grant”).

The Grants were offered as material inducement to the employees’ employment. The grants were approved by the Compensation Committee of the Company’s Board of Directors pursuant to the Company’s Inducement Plan to motivate and reward the recipients to perform at the highest levels and contribute significantly to the success of the Company. The Grants were made in reliance on the employment inducement exemption under the NYSE’s Listed Company Manual Rule 303A.08.

The Company is issuing this press release pursuant to Rule 303A.08. The Grants shall vest and become exercisable 25% on the first anniversary of the grant date, and 1/48th of the aggregate number of shares subject to the award on each monthly anniversary of the grant date thereafter, such that the entire award will be vested as of the fourth anniversary of the grant date, subject to continued employment with the Company.

About ADC Therapeutics

ADC Therapeutics (NYSE: ADCT) is a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs). The Company is advancing its proprietary ADC technology to transform the treatment paradigm for patients with hematologic malignancies and solid tumors.

ADC Therapeutics’ CD19-directed ADC ZYNLONTA (loncastuximab tesirine-lpyl) received accelerated approval by the FDA and conditional approval from the European Commission for the treatment of relapsed or refractory diffuse large B-cell lymphoma after two or more lines of systemic therapy. ZYNLONTA is also in development in combination with other agents and in earlier lines of therapy. In addition to ZYNLONTA, ADC Therapeutics has multiple ADCs in ongoing clinical and preclinical development.

ADC Therapeutics is based in Lausanne (Biopôle), Switzerland, and has operations in London and New Jersey. For more information, please visit https://adctherapeutics.com/ and follow the Company on LinkedIn.

ZYNLONTA® is a registered trademark of ADC Therapeutics SA.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In some cases you can identify forward-looking statements by terminology such as “may”, “will”, “should”, “would”, “expect”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “predict”, “potential”, “seem”, “seek”, “future”, “continue”, or “appear” or the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Forward-looking statements are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to: the expected cash runway into mid-2026 the Company’s ability to grow ZYNLONTA® revenue in the United States; the ability of our partners to commercialize ZYNLONTA® in foreign markets, the timing and amount of future revenue and payments to us from such partnerships and their ability to obtain regulatory approval for ZYNLONTA® in foreign jurisdictions; the timing and results of the Company’s or its partners’ research and development projects or clinical trials including LOTIS 5 and 7, ADCT 602 as well as early research in certain solid tumors with different targets, linkers and payloads; the timing and results of investigator-initiated trials including those studying FL and MZL and the potential regulatory and/or compendia strategy and the future opportunity; the timing and outcome of regulatory submissions for the Company’s products or product candidates; actions by the FDA or foreign regulatory authorities; projected revenue and expenses; the Company’s indebtedness, including Healthcare Royalty Management and Blue Owl and Oaktree facilities, and the restrictions imposed on the Company’s activities by such indebtedness, the ability to comply with the terms of the various agreements and repay such indebtedness and the significant cash required to service such indebtedness; and the Company’s ability to obtain financial and other resources for its research, development, clinical, and commercial activities. Additional information concerning these and other factors that may cause actual results to differ materially from those anticipated in the forward-looking statements is contained in the “Risk Factors” section of the Company’s Annual Report on Form 10-K and in the Company’s other periodic and current reports and filings with the U.S. Securities and Exchange Commission. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance, achievements or prospects to be materially different from any future results, performance, achievements or prospects expressed in or implied by such forward-looking statements. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document.

CONTACTS:

Investors
Marcy Graham
ADC Therapeutics
Marcy.Graham@adctherapeutics.com
+1 650-667-6450

Media
Nicole Riley
ADC Therapeutics
Nicole.Riley@adctherapeutics.com
+1 862-926-9040

View original content to download multimedia:https://www.prnewswire.com/news-releases/adc-therapeutics-makes-grants-to-new-employees-under-inducement-plan-302338599.html

SOURCE ADC Therapeutics SA

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Ampace Spotlights AI-Ready Battery Solutions for Gigascale Infrastructure at DCW Washington 2026

Published

on

By

WASHINGTON, April 21, 2026 /PRNewswire/ — Ampace, a global leader in advanced lithium-ion battery technology, is participating in Data Center World 2026 at the Walter E. Washington Convention Center (Booth 206), where active visitor engagement reflected growing industry focus on how power infrastructure must evolve for the AI era.

This year, Ampace is showcasing how battery systems are becoming an increasingly important enabler of gigascale AI infrastructure. From cell-level technologies to system-level deployment, spanning applications from commercial and industrial energy storage to UPS systems, Ampace is presenting solutions designed to help data centers manage rising power volatility, improve resilience, and scale more efficiently.

At the center of the showcase is the PU Series, Ampace’s AI-ready battery platform engineered for the increasingly dynamic conditions of modern compute environments. As AI clusters drive 100kW+ rack densities, millisecond-level load spikes, and frequent workload transitions, conventional backup systems are being asked to do far more than emergency support. Ampace’s PU Series is designed to absorb rapid fluctuations, maintain stable output, and support uninterrupted operation under highly variable AI workloads.

A key highlight of Ampace’s presence this week will be its featured TECH TALK session with Eaton on April 22, from 2:30 PM to 3:15 PM (Room 209ABC), titled Powering Gigascale AI: How Advanced Batteries Stabilize Extreme Training Loads.

The session will bring together shared industry perspectives from Aaron Schott, UPS Sales Manager at Ampace, and Jon Hymel, Product Manager at Eaton, two professionals working closely with hyperscale, colocation, enterprise, and mission-critical customers navigating the next wave of AI infrastructure growth.

Together, the speakers will explore how established UPS architectures and advanced lithium battery systems are increasingly working in tandem to meet the operational realities of AI data centers. The discussion will examine how battery technologies can support real-time load balancing, improve reliability, and help operators prepare for the transition from megawatt-scale campuses to gigawatt-scale compute ecosystems.

Their joint appearance reflects a growing alignment across the power infrastructure ecosystem: scalable AI requires not only more electricity, but smarter coordination between UPS systems, energy storage, and facility operations. As data centers evolve, battery-enabled continuity is becoming a shared priority across technology providers, operators, and infrastructure partners.

Built for demanding AI applications, Ampace’s platform is engineered to respond rapidly during ramp-up and ramp-down events, while maintaining stable operation under continuous partial-load cycling. Its semi-solid cell technology further enhances intrinsic safety by reducing leakage risk and lowering thermal runaway gas generation, while cabinet-level validation under UL 9540A standards reinforces readiness for mission-critical deployments.

At Ampace’s booth, visitors have been exploring how advanced battery systems can help reduce infrastructure oversizing, relieve pressure on grid connections, and improve continuity in facilities originally designed for steady-state demand. The strong response reflects a broader market shift: batteries are no longer viewed only as standby assets, but as active components of modern AI power architecture.

Visit Booth 206 to meet the Ampace team, experience the PU Series on site, and join in-depth discussions on how advanced battery solutions are helping build a more resilient, scalable, and efficient AI infrastructure. On-site specialists are available throughout the show for live demonstrations, technical briefings, and media inquiries.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ampace-spotlights-ai-ready-battery-solutions-for-gigascale-infrastructure-at-dcw-washington-2026-302749593.html

SOURCE Ampace

Continue Reading

Technology

TÜV Rheinland Opens Advanced Automotive Component Testing Laboratory in Manesar, Haryana

Published

on

By

Empowering automotive industry capabilities through precision testing, international compliance, and innovative solutions for next-generation mobility.

MANESAR, India, April 22, 2026 /PRNewswire/ — TÜV Rheinland, a global leader in independent testing, inspection and certification services, today announced the opening of its state-of-the-art Automotive Component Testing Laboratory (ACT Lab) in Manesar, Haryana. The ACT Lab will support manufacturers in meeting evolving regulatory requirements, adopting emerging technologies, and accelerating time-to-market.

As the world’s third-largest mobility market, India is developing rapidly, and demand for trustworthy, globally recognized testing services continues to rise. TÜV Rheinland’s ACT Lab supports the development of safer and high-performance automotive products.

Strategically located in Manesar, the facility is well-positioned to unlock growth opportunities within India’s automotive and electric mobility ecosystem, while advancing next-generation transport solutions.

Technological Excellence and Advanced Capabilities

The ACT Lab is equipped with advanced testing systems from leading international manufacturers, ensuring precision, reliability, and global acceptance of results.

Its capabilities include structural testing, corrosion and durability assessments, and environmental simulation under extreme conditions. The facility also offers fatigue and lifecycle testing for critical automotive components, alongside comprehensive material analysis for metals and polymers, delivering deep insights into performance under real-world conditions.

By providing end-to-end testing, inspection, and certification solutions under one roof, the lab distinguishes itself through its ability to replicate operational environments, meet global and OEM standards, and deliver highly reliable, traceable results.

Platform for Collaboration, Innovation, and Trust

Commenting on the inauguration, Dr. Matthias Schubert, Executive Vice President Mobility at TÜV Rheinland Group, said: “Our investment in the Automotive Component Testing Laboratory in Manesar reflects TÜV Rheinland’s long-term strategic commitment to India as a key growth market. As the mobility sector undergoes rapid transformation, this facility enables us to support manufacturers with advanced testing capabilities that not only ensure compliance but also drive innovation, safety, and global competitiveness.”

Highlighting the broader strategic intent, Thomas Quernheim, Senior Vice President Mobility, TÜV Rheinland Group, said, “India represents one of the most dynamic opportunities within our global mobility portfolio. This investment reflects our vision to build resilient, future-oriented capabilities that not only respond to market evolution but also shape the standards of tomorrow’s mobility ecosystem.”

Rajendra Kisanrao Bandal, Vice President, Mobility at TÜV Rheinland India, added: “This facility goes beyond a conventional testing laboratory – it is a platform for collaboration and innovation. Combining global expertise with local insight, it enables manufacturers to enhance quality, reliability, and performance, while strengthening India’s position in the global mobility landscape.”

About TÜV Rheinland:

TÜV Rheinland is a leading provider of testing and inspection services worldwide. For over 150 years, the company has helped make the world a safer place. Today, more than 28,000 employees test, inspect and certify products, plants and processes, while also providing training for people in a wide range of professions. Operating from 500 locations in more than 50 countries, TÜV Rheinland helps safeguard key areas of business and everyday life. Headquartered in Cologne and generating annual revenue of close to €3 billion, the company plays a key role in quality assurance worldwide. TÜV Rheinland has been a member of the UN Global Compact since 2006, demonstrating its commitment to anti-corruption and sustainability.

Website: Click here

Media Contact:

Samrat Sinha
Communications & PR
TÜV Rheinland
Email: Samrat.Sinha@ind.tuv.com

Photo – https://mma.prnewswire.com/media/2961708/Manesar_Lab_Pic_Edited_Without_Barbed_Wire.jpg

View original content:https://www.prnewswire.com/in/news-releases/tuv-rheinland-opens-advanced-automotive-component-testing-laboratory-in-manesar-haryana-302748539.html

Continue Reading

Technology

EZVIZ joins the United Nations Global Compact, starting a new chapter of its unwavering journey to long-term sustainability and further expanding its contribution to key environmental issues

Published

on

By

HOOFDDORP, Netherlands, April 22, 2026 /PRNewswire/ — EZVIZ, an advocate for greener smart homes, is proud to announce its participation in the United Nations Global Compact (UNGC) in the International Year of Volunteers for Sustainable Development on this Earth Day. As a smart home pioneer joining the world’s largest corporate sustainability initiative, EZVIZ will align its award-winning EZVIZ Green initiative with the UNGC’s Ten Principles, making a transformative impact through responsible business in environmental protection.

The UN Global Compact is a call to companies to adopt ten universal principles in human rights, labour, environment and anti-corruption, and to support the Sustainable Development Goals (SDGs). With over 25,000 participants across 167 countries, the UNGC is keeping the earth green and clean with its growing influence.

Though new to the initiative, EZVIZ has been implementing SDGs in its development, operations and management, including establishing an ESG committee directed by the Board. On April 10, the company published its 2025 ESG report under its commitment “Our Planet. Our Actions” for transparency and awareness. Over the past year, EZVIZ has received international recognition like the European Green Awards, the SEAL Sustainability Business Awards, and the Indigo Design Award with the “Design for Social Change” honor.

To safeguard a green planet, EZVIZ has addressed land degradation, global warming, plastic recycling, community empowerment and more. Partnering with Treedom, EZVIZ has planted 4,190 trees with local farmers, reducing approximately 738.2 tons of CO2. Together with Plastic Bank, EZVIZ has prevented over 1,000,000 plastic bottles from polluting vulnerable environments. The partnerships are reinforced by internally recycling plastics and minimizing waste. In 2025, EZVIZ incorporated over 30 tons of recycled materials into its RE7 Edge robot vacuum’s design and reduced CO2 emissions by 73.1 tons through greener packaging.

“Becoming part of the UNGC is a significant milestone for us. It means our efforts in building a better planet, have been recognized globally,” said Jingwen Cao, EZVIZ Board Secretary and Director of the ESG Committee. “This participation provides us the confidence to further expand our environmental protection, as well as to set stricter boundaries to avoid sacrificing the environment for commercial gain.”

With green in its brand gene, the company has also developed green technology with a low carbon footprint. The AOV low-energy consumption tech, and the ColorFULL low-light night vision mode help reduce energy consumption and light pollution resulted from 24/7 home security. Firstly embedding self-patented wild animal detection in outdoor cameras, EZVIZ continues to implement responsible AI to balance human safety and wildlife protection, according to Sophie Zhang, EZVIZ Global Brand Director.

“We believe in the power of technology and always strive to benefit not only our users, but also everyone and every life,” said Zhang. “Alongside other industry leaders in the UNGC, EZVIZ is motivated to contribute to a better future for generations to come.”

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/ezviz-joins-the-united-nations-global-compact-starting-a-new-chapter-of-its-unwavering-journey-to-long-term-sustainability-and-further-expanding-its-contribution-to-key-environmental-issues-302745969.html

SOURCE EZVIZ

Continue Reading

Trending